Omada Health

Omada Health

OMDA
Omada HealthUS flagNASDAQ Global Market
17.79
USD
-0.59
- -
1.06BMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.87
2.57
3.05
7.1
5.76
Basic EPS, GAAP
-1.52
-1.41
-0.85
-0.35
-0.13
Free Cash Flow per Basic Share
-1.5
-1.1
-0.68
0.46
0.44
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
-6.9
-8.32
-7.96
-12.46
-9.35
Tangible Book Value per Share
-6.59
-7.75
-15.27
5.84
4.45
Basic Weighted Avg Shares
48
48
56
37
49
Sales/Revenue/Turnover
89
123
170
260
283
Operating Margin (%)
-81.12
-53.75
-25.71
-4.6
-2.95
Depreciation Expense
4
4
5
5
6
Net Income, GAAP
-73
-68
-47
-13
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
-81.31
-54.98
-27.76
-4.91
-2.22
Working Capital
154
99
59
197
201
LT Debt
30
30
30
- -
- -
Total Equity
156
99
-384
230
234
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
3.52
Return on Common Equity (%)
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
58
58
59
Market Capitalization
998
763
618

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
255
273
269
Cash, Cash Equivalents & STI
199
222
212
Accounts Receivable, Net
19
14
14
Inventories
3
4
4
Total Current Liabilities
70
76
69
Payables & Accruals
43
26
39
ST Debt
- -
- -
- -
Deferred Revenue
27
25
29

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-159.75%
Free Cash Flow
- -
- -
-144.5%
Net Income, GAAP
- -
- -
-72.89%
Sales/Revenue/Turnover
- -
- -
53.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
35
41
- -
- -
170
2025
55
61
68
76
260
2026
78
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.4
-0.22
- -
- -
-0.85
2025
-0.17
-0.24
-0.06
0.09
-0.35
2026
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Sean Duffy
Full Time Employees
849
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500 Sansome Street San Francisco CA United States of America 94111
IPO Date
Jun 6, 2025
Business
Omada Health Omada Health, Inc. provides virtual care programs focused on chronic condition management in the United States; its core offerings include cardiometabolic programs for prediabetes, diabetes, hypertension, and weight management with personalized health coaching, connected devices such as scales, blood pressure monitors, and glucose meters, interactive lessons, peer communities, and virtual physician support; musculoskeletal programs addressing joint and muscle conditions through physical therapy; behavioral health support; and integrated care for members using glucagon-like peptide-1 agonists. The company serves employers, health plans, pharmacy benefit managers, and health systems via direct sales and channel partners, operating primarily from its San Francisco, California headquarters where it was founded in 2011. Recent developments encompass its June 2025 initial public offering on Nasdaq under ticker OMDA raising approximately $150 million, partnerships including Amazon Health Condition Programs launched in 2024 and collaborations with Cigna, nationwide prescribing capability for anti-obesity medications announced in 2025, the 2020 acquisition of Physera to expand musculoskeletal services, and URAC accreditation for MSK care plus NCQA accreditation for diabetes programs achieved in recent years.

Company News

APIChat
  • Omada Health to Participate in Goldman Sachs Global Healthcare Conference

  • Omada Health Q1 Earnings Call Highlights

  • Omada Health, Inc. (OMDA) Q1 2026 Earnings Call Transcript

  • Compared to Estimates, Omada Health, Inc. (OMDA) Q1 Earnings: A Look at Key Metrics

  • Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support

  • Omada Health Reports First Quarter 2026 Results

  • Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds

  • Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026

  • Omada Health, Inc. (NASDAQ:OMDA) Receives Average Rating of “Moderate Buy” from Analysts

  • Wall Street Analysts Believe Omada Health, Inc. (OMDA) Could Rally 59.53%: Here's is How to Trade

  • Could This $14 Stock Be Your Ticket to Millionaire Status?

  • Omada Health (NASDAQ:OMDA) vs. Nutex Health (NASDAQ:NUTX) Financial Contrast

  • Omada Health: GLP-1-Focused Telehealth Platform Users May Feel They Can Do Without

  • Omada Health, Inc. (OMDA) Q4 2025 Earnings Call Transcript

  • Compared to Estimates, Omada Health, Inc. (OMDA) Q4 Earnings: A Look at Key Metrics

  • Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care

  • Omada Health Reports Fourth Quarter and Full-Year 2025 Results

  • Omada Adds Cholesterol Care to Its Integrated Platform, Addressing the Silent Driver of Cardiovascular Risk

  • Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026

  • Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript